Dr. Tony Holohan:

I will come in on the clinical audit and patient safety Bill in a moment. With regard to Professor Flannelly, I can also point out, while others are pointing out what she did with the HPV vaccine, that she was one of the people instrumental in helping to get the political buy-in to establish the programme. She had recently come back, if I recall correctly, from the UK and I remember her testimony about her shock at seeing women who were young coming with late stage presentations of gynaecological malignancies that were often preventable. The programme that she developed and directed for ten years is another contribution that she has made to saving lives.